09:38 EDT Monte Rosa Therapeutics (GLUE) files $400M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- Monte Rosa Therapeutics Reports Q4 2024 Financial Results
- Monte Rosa Therapeutics announces anticipated upcoming milestones
- Monte Rosa Therapeutics sees cash runway into 2028
- Monte Rosa Therapeutics reports Q4 revenue $60.6M, consensus $51.9M
- Monte Rosa Therapeutics announces results from MRT-6160, MRT-2359 programs